152 related articles for article (PubMed ID: 30814402)
1. Anti-inflammatory, anti-oxidative stress and novel therapeutic targets for cholestatic liver injury.
Zhang Y; Lu Y; Ji H; Li Y
Biosci Trends; 2019 Mar; 13(1):23-31. PubMed ID: 30814402
[TBL] [Abstract][Full Text] [Related]
2. Loss of cellular FLICE-inhibitory protein promotes acute cholestatic liver injury and inflammation from bile duct ligation.
Gehrke N; Nagel M; Straub BK; Wörns MA; Schuchmann M; Galle PR; Schattenberg JM
Am J Physiol Gastrointest Liver Physiol; 2018 Mar; 314(3):G319-G333. PubMed ID: 29191940
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic targets for cholestatic liver injury.
Woolbright BL; Jaeschke H
Expert Opin Ther Targets; 2016; 20(4):463-75. PubMed ID: 26479335
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of bile acid mediated inflammation in the liver.
Li M; Cai SY; Boyer JL
Mol Aspects Med; 2017 Aug; 56():45-53. PubMed ID: 28606651
[TBL] [Abstract][Full Text] [Related]
5. Early growth response factor-1 is critical for cholestatic liver injury.
Kim ND; Moon JO; Slitt AL; Copple BL
Toxicol Sci; 2006 Apr; 90(2):586-95. PubMed ID: 16423862
[TBL] [Abstract][Full Text] [Related]
6. The expression levels of plasma membrane transporters in the cholestatic liver of patients undergoing biliary drainage and their association with the impairment of biliary secretory function.
Shoda J; Kano M; Oda K; Kamiya J; Nimura Y; Suzuki H; Sugiyama Y; Miyazaki H; Todoroki T; Stengelin S; Kramer W; Matsuzaki Y; Tanaka N
Am J Gastroenterol; 2001 Dec; 96(12):3368-78. PubMed ID: 11774951
[TBL] [Abstract][Full Text] [Related]
7. Bile acids initiate cholestatic liver injury by triggering a hepatocyte-specific inflammatory response.
Cai SY; Ouyang X; Chen Y; Soroka CJ; Wang J; Mennone A; Wang Y; Mehal WZ; Jain D; Boyer JL
JCI Insight; 2017 Mar; 2(5):e90780. PubMed ID: 28289714
[TBL] [Abstract][Full Text] [Related]
8. [Role of early growth response factor-1 signal pathway in acute intrahepatic cholestatic hepatic injury in rats].
Ding Y; Zhao L; Huang ZH; Mei H; Peng HM
Zhonghua Gan Zang Bing Za Zhi; 2008 Mar; 16(3):215-9. PubMed ID: 18364083
[TBL] [Abstract][Full Text] [Related]
9. Early Alterations of Bile Canaliculi Dynamics and the Rho Kinase/Myosin Light Chain Kinase Pathway Are Characteristics of Drug-Induced Intrahepatic Cholestasis.
Burbank MG; Burban A; Sharanek A; Weaver RJ; Guguen-Guillouzo C; Guillouzo A
Drug Metab Dispos; 2016 Nov; 44(11):1780-1793. PubMed ID: 27538918
[TBL] [Abstract][Full Text] [Related]
10. Bile Acids in Cholestasis and its Treatment.
Arab JP; Cabrera D; Arrese M
Ann Hepatol; 2017 Nov; 16(Suppl. 1: s3-105.):s53-s57. PubMed ID: 29080340
[TBL] [Abstract][Full Text] [Related]
11. Bile acid homeostasis paradigm and its connotation with cholestatic liver diseases.
Yang T; Khan GJ; Wu Z; Wang X; Zhang L; Jiang Z
Drug Discov Today; 2019 Jan; 24(1):112-128. PubMed ID: 30244079
[TBL] [Abstract][Full Text] [Related]
12. [New molecular features of cholestatic diseases of the liver].
Méndez-Sánchez N; Chavez-Tapia NC; Uribe M
Rev Invest Clin; 2003; 55(5):546-56. PubMed ID: 14968476
[TBL] [Abstract][Full Text] [Related]
13. Mitochondria protection as a mechanism underlying the hepatoprotective effects of glycine in cholestatic mice.
Heidari R; Ghanbarinejad V; Mohammadi H; Ahmadi A; Ommati MM; Abdoli N; Aghaei F; Esfandiari A; Azarpira N; Niknahad H
Biomed Pharmacother; 2018 Jan; 97():1086-1095. PubMed ID: 29136945
[TBL] [Abstract][Full Text] [Related]
14. Dexamethasone counteracts hepatic inflammation and oxidative stress in cholestatic rats via CAR activation.
Gabbia D; Pozzo L; Zigiotto G; Roverso M; Sacchi D; Dalla Pozza A; Carrara M; Bogialli S; Floreani A; Guido M; De Martin S
PLoS One; 2018; 13(9):e0204336. PubMed ID: 30252871
[TBL] [Abstract][Full Text] [Related]
15. Novel insight into mechanisms of cholestatic liver injury.
Woolbright BL; Jaeschke H
World J Gastroenterol; 2012 Sep; 18(36):4985-93. PubMed ID: 23049206
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of cholestasis.
Zollner G; Trauner M
Wien Med Wochenschr; 2006 Jul; 156(13-14):380-5. PubMed ID: 16937039
[TBL] [Abstract][Full Text] [Related]
17. [Intrahepatic cholestasis: modulation by immunological factors?].
Marbet UA; Shefer S; Leevy CM
Schweiz Med Wochenschr; 1986 Jul; 116(29):969-70. PubMed ID: 3764380
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of SRT1720 via the HNF1α/FXR signalling pathway and anti-inflammatory mechanisms in mice with estrogen-induced cholestatic liver injury.
Yu L; Liu X; Li X; Yuan Z; Yang H; Zhang L; Jiang Z
Toxicol Lett; 2016 Dec; 264():1-11. PubMed ID: 27818225
[TBL] [Abstract][Full Text] [Related]
19. The Role of Inflammation in the Mechanisms of Bile Acid-Induced Liver Damage.
Cai SY; Boyer JL
Dig Dis; 2017; 35(3):232-234. PubMed ID: 28249287
[TBL] [Abstract][Full Text] [Related]
20. Loss of c-Met signaling sensitizes hepatocytes to lipotoxicity and induces cholestatic liver damage by aggravating oxidative stress.
Gomez-Quiroz LE; Seo D; Lee YH; Kitade M; Gaiser T; Gillen M; Lee SB; Gutierrez-Ruiz MC; Conner EA; Factor VM; Thorgeirsson SS; Marquardt JU
Toxicology; 2016 Jun; 361-362():39-48. PubMed ID: 27394961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]